Volume 9, Number 11—November 2003
Commentary
Frequency of Revaccination against Smallpox
Samuel Baron*
, Jingzhi Pan*, and Joyce Poast*
, Jingzhi Pan*, and Joyce Poast*
Table
Residual vaccinia virus neutralizing titers of serum from vaccinated and unvaccinated persons
| Participant no. |
Y after vaccination | Neutralizing titer |
|---|---|---|
| Single-vaccinated persons | ||
| A |
47 |
10 |
| B |
50 |
26 |
| C |
45 |
27 |
| D |
40 |
34 |
| E |
40 |
43 |
| Ordinary commercial immunoglobulin (Panglobulin) |
150 |
|
| Unvaccinated persons |
||
| H6 |
—a |
<10 |
| H9 |
— |
<10 |
| C2 |
— |
<10 |
| C4 |
— |
<10 |
| H1 |
— |
10 |
| H2 |
— |
10 |
| H13 |
— |
10 |
| C1 |
— |
10 |
| C3 |
— |
10 |
| H7 |
— |
10 |
| HL |
— |
20 |
| H3 |
— |
20 |
| H4 |
— |
20 |
| H5 |
— |
20 |
| H10 |
— |
20 |
| H11 |
— |
20 |
| H12 |
— |
20 |
| C7 |
— |
20 |
| H8 | — | 30 |
a—, Not applicable.
Page created: January 20, 2011
Page updated: January 20, 2011
Page reviewed: January 20, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.